All Articles

Sphere Entertainment's earnings show a stark divide: soaring success from its futuristic venues clashes with the steady decline of its legacy media arm.

Amidst high interest rates and a 5.6% drop in new home sales, MPCs are up 3%. This isn't just a trend; it's a fundamental shift in homebuyer priorities.

While rivals stumble, NextDecade's Rio Grande LNG facility is ahead of schedule, backed by savvy financing. A deep dive into their blueprint for success.

A $3.8M one-time gain drove record Q2 earnings for Bank of Botetourt, but a deeper look reveals robust core operations and a savvy long-term strategy.

Nutrabolt is pushing its C4 brand beyond energy drinks with a new sparkling protein beverage. This isn't just a new flavor—it's a strategic invasion of a multi-billion dollar market.

Health-E Commerce is building a new network, linking telehealth, prescriptions, and pre-tax health funds into one intelligent, frictionless system.

Audience Town's new conversational AI aims to give small marketing teams the power of big data, but does this hyper-specialized tool deliver on its promise?

As the AI boom's energy and water use soars, cloud provider Nebius details a blueprint for responsible scaling, blending engineering efficiency with community benefits.

A Pennsylvania clinic's radical 19-day protocol, powered by advanced hyperbaric tech, is showing remarkable results for veterans with TBI and PTSD.

A new fintech, 1TCH, has launched a single platform for payments, projects, and invoicing. Is this ambitious all-in-one the future for freelancers?

By ceding a $5.8B legacy block, Lincoln is doubling down on its strategy to enhance cash flow and fortify its balance sheet for long-term resilience.

Etsy's divestiture of Depop to eBay is more than a sale; it's a strategic reset. We explore the why behind this billion-dollar e-commerce shake-up.

A favorable valuation for pre-revenue HG Home Guardian validates its vision for proactive home care, signaling a major shift from reactive fixes to predictive intelligence.

Clinical research leader Novotech offers a strategic roadmap for biotech and pharma, aiming to de-risk and accelerate the complex world of autoimmune drug development.

With a new $463M war chest and a former Optum CEO on its board, health benefits innovator Gravie is escalating its challenge to the industry establishment.

South Korean robotic hand specialist Tesollo targets a post-2027 IPO, fueled by strategic Series B funding and a mission to dominate industrial automation.

With a lens clinically shown to stop nearsightedness in 9 of 10 kids, HOYA isn't just launching a product; it's making a power play in a blurry market.

eBay's acquisition of Depop isn't just about clothes; it's a high-stakes play for relevance, a bid to capture the circular economy, and a test of survival.

With a new CEO known for navigating tough markets and a strategic move to Houston, Alléo Energy is shifting from R&D to commercial execution.

A startup is using real neurons to discover software that slashes AI costs. We analyze the tech, the market, and the profound implications of this new frontier.